Quetiapine
- Generic Name
- Quetiapine
- Brand Names
- Seroquel
- Drug Type
- Small Molecule
- Chemical Formula
- C21H25N3O2S
- CAS Number
- 111974-69-7
- Unique Ingredient Identifier
- BGL0JSY5SI
- Background
Initially approved by the FDA in 1997, quetiapine is a second-generation atypical antipsychotic used in schizophrenia, major depression, and bipolar disorder. Quetiapine demonstrates a high level of therapeutic efficacy and low risk of adverse effects during long-term treatment. It is well-tolerated and a suitable option for some patients with high sensitivi...
- Indication
Quetiapine is used in the symptomatic treatment of schizophrenia. In addition, it may be used for the management of acute manic or mixed episodes in patients with bipolar I disorder, as a monotherapy or combined with other drugs. It may be used to manage depressive episodes in bipolar disorder. In addition to the above indications, quetiapine is used in comb...
- Associated Conditions
- Bipolar 1 Disorder, Depressive Episodes, Generalized Anxiety Disorder, Major Depressive Disorder (MDD), Mixed manic depressive episode, Post Traumatic Stress Disorder (PTSD), Psychosis, Schizophrenia, Acute Manic episode
- Associated Therapies
- -
Functional and Neurochemical Brain Changes in First-episode Bipolar Mania
- First Posted Date
- 2008-02-06
- Last Posted Date
- 2015-12-07
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 81
- Registration Number
- NCT00609193
- Locations
- 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States
A Double Blind, Placebo Controlled Trial of Quetiapine in Anorexia Nervosa, a Dual Site Study
- Conditions
- First Posted Date
- 2008-01-02
- Last Posted Date
- 2012-06-18
- Lead Sponsor
- University of South Florida
- Target Recruit Count
- 24
- Registration Number
- NCT00584688
- Locations
- 🇺🇸
University of South Floirda, Tampa, Florida, United States
Methamphetamine-Quetiapine Interactions in Humans
- First Posted Date
- 2007-12-05
- Last Posted Date
- 2010-07-13
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 10
- Registration Number
- NCT00567866
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Quetiapine Augmentation Versus Clomipramine Augmentation of SSRI for Obsessive-compulsive Disorder Patients
- Conditions
- Interventions
- First Posted Date
- 2007-11-28
- Last Posted Date
- 2017-10-27
- Lead Sponsor
- University of Sao Paulo
- Target Recruit Count
- 21
- Registration Number
- NCT00564564
- Locations
- 🇧🇷
Institute of Psychiatry, Clinics Hospital, University of São Paulo Medical School, São Paulo, SP, Brazil
Quetiapine Induced Neuroplasticity in First-episode Schizophrenic Patients
- First Posted Date
- 2007-11-07
- Last Posted Date
- 2011-10-24
- Lead Sponsor
- University of Regensburg
- Target Recruit Count
- 30
- Registration Number
- NCT00554658
- Locations
- 🇩🇪
University of Regensburg, Department of Psychiatry, Regensburg, Germany
Quetiapine and Concerta in the Treatment for ADHD and Aggressive Behavior.
- Conditions
- Interventions
- First Posted Date
- 2007-10-29
- Last Posted Date
- 2015-05-13
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 30
- Registration Number
- NCT00550147
- Locations
- 🇺🇸
Riley Childrens Hospital, Indianapolis, Indiana, United States
Schizophrenia Sensory Gating Deficit With Quetiapine
- Conditions
- First Posted Date
- 2007-09-28
- Last Posted Date
- 2007-12-31
- Lead Sponsor
- New Mexico VA Healthcare System
- Target Recruit Count
- 20
- Registration Number
- NCT00536783
- Locations
- 🇺🇸
New Mexico VA Healthcare System, Albuquerque, New Mexico, United States
Trial of Quetiapine in Anorexia Nervosa
- First Posted Date
- 2007-08-21
- Last Posted Date
- 2019-07-17
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 21
- Registration Number
- NCT00518973
- Locations
- 🇺🇸
UCSD Department of Psychiatry Center for Eating Disorder Research, San Diego, California, United States
Glucose and Lipid Metabolism on Antipsychotic Medication
- Conditions
- Interventions
- First Posted Date
- 2007-08-14
- Last Posted Date
- 2019-10-02
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 96
- Registration Number
- NCT00515723
- Locations
- 🇺🇸
Washington Univeristy School of Medicine, Saint Louis, Missouri, United States
🇺🇸Washington University School of Medicine, Psychiatry Dept., Saint Louis, Missouri, United States
FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis
- Conditions
- First Posted Date
- 2007-06-15
- Last Posted Date
- 2010-12-10
- Lead Sponsor
- AstraZeneca
- Registration Number
- NCT00486798
- Locations
- 🇸🇪
Research Site, Vaxjo, Sweden
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.